Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 1Completed 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1Classical hematology 1

Conditions

Leukemia 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Burkitt Lymphoma 8Leukemia, Myeloid, Acute 5Myelodysplastic Syndromes 4Lymphoma 4Leukemia, Myelomonocytic, Chronic 4Anemia, Refractory, with Excess of Blasts 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Myeloproliferative Disorders 3Leukemia, Biphenotypic, Acute 3Down Syndrome 3Myelodysplastic-Myeloproliferative Diseases 2Leukemia, Promyelocytic, Acute 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Anemia, Refractory 2Optic Nerve Glioma 1Neutropenia 1Neoplasm Metastasis 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Eosinophilic, Acute 1Dendritic Cell Sarcoma, Interdigitating 1Congenital Abnormalities 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Cytarabine 19Daunorubicin 14Etoposide 13Mitoxantrone 8Filgrastim 8Peripheral Blood Stem Cell Transplantation 6Idarubicin 6Gemtuzumab 5Cyclophosphamide 5Radiotherapy 4Observation 4valspodar 3aldesleukin 3Tretinoin 3Busulfan 3sargramostim 2Watchful Waiting 2Thioguanine 2Granulocyte Colony-Stimulating Factor 2Asparaginase 2Amsacrine 2zosuquidar trihydrochloride 1tipifarnib 1midostaurin 1lintuzumab 1laromustine 1fludarabine phosphate 1flt3 ligand protein 1etoposide phosphate 1dexamethasone acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Leukemia, Erythroblastic, Acute × Thioguanine × Clear all
NCT00002658 2013-12-19

Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
2,000 enrolled
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Neutropenia, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

NCT00005823 2013-12-18

Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

National Cancer Institute (NCI)

Phase 3 Completed
2,000 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Acute, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡